Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2005
12/15/2005WO2005118016A1 Medical device comprising a biologically active agent
12/15/2005WO2005118009A2 Transdermal delivery system for treatment of cognitive disorders
12/15/2005WO2005117999A2 Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface
12/15/2005WO2005117997A1 Ligands having metal binding ability and targeting properties
12/15/2005WO2005117995A1 Application of hyaluronic acid to sentinel lymph node identification
12/15/2005WO2005117992A2 Controlled delivery of therapeutic compounds
12/15/2005WO2005117988A1 Antibody colour pigment conjugates for changing eye color appearance
12/15/2005WO2005117987A1 Antibody conjugates targeting to ocular proteins
12/15/2005WO2005117986A2 Antibody drug conjugates and methods
12/15/2005WO2005117985A2 Lipopolyplex construct with an integrin binding peptide for delivery of nucleic acids, peptides or drugs
12/15/2005WO2005117984A2 Albumin-binding conjugates comprising a fatty acid and peg
12/15/2005WO2005117983A2 Carrier conjugates of tnf-peptides
12/15/2005WO2005117982A1 Ocular formulations with neuroprotectants to reduce alzheimer and neurotoxic risks created by large zinc dosages
12/15/2005WO2005117977A2 Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface
12/15/2005WO2005117967A2 Anti-il-9 antibody formulations and uses thereof
12/15/2005WO2005117965A1 Methods for preparing immunogenic conjugates
12/15/2005WO2005117963A1 Medical uses of carrier conjugates of non-human tnf-peptides
12/15/2005WO2005117958A1 Vaccine compositions comprising virosomes and a saponin adjuvant
12/15/2005WO2005117952A2 Treatment methods utilizing albumin-binding proteins as targets
12/15/2005WO2005117951A1 Methods and formulations for increasing intestinal function
12/15/2005WO2005117948A1 Method of stabilizing proteins
12/15/2005WO2005117932A1 Bisubstrate inhibitors of protein tyrosine kinases as therapeutic agents
12/15/2005WO2005117928A1 Compositions and methods for the treatment of skin cancer
12/15/2005WO2005117905A2 Systems and methods for treating panic attacks
12/15/2005WO2005117904A2 Phosphonate analogs of hiv integrase inhibitor compounds
12/15/2005WO2005117901A1 Oral formulations of paricalcitol
12/15/2005WO2005117899A1 Pharmaceutical composition comprising tibolone and process for procuding the same
12/15/2005WO2005117886A1 Adhesive patch
12/15/2005WO2005117878A1 Irinotecan preparation
12/15/2005WO2005117845A1 Oral preparations and process for production thereof
12/15/2005WO2005117843A2 Sustained release preparations
12/15/2005WO2005117838A1 Stable oral pharmaceutical compositions of buprenorphine and derivatives
12/15/2005WO2005117832A1 Liposomal assembly for therapeutic and/or diagnostic use
12/15/2005WO2005117831A1 Injectable pharmaceutical suspension comprising posaconazole
12/15/2005WO2005117810A1 External preparation for the skin
12/15/2005WO2005117803A1 Process for producing edible oral administration preparation of aggregated substance-containing laminated film, and edible oral administration preparation of aggregated substance-containing laminated film
12/15/2005WO2005103263B1 Bone delivery conjugates and method of using same to target proteins to bone
12/15/2005WO2005099752A9 Antigen delivery vectors and constructs
12/15/2005WO2005099361A3 MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN
12/15/2005WO2005090570A9 Therapeutic compositions and methods for treating diseases that involve angiogenesis
12/15/2005WO2005084751A3 Implantable system for controlling gene expression
12/15/2005WO2005079155A3 Photoreactive compound specifically binding to calcium binding proteins
12/15/2005WO2005069966A3 Vascular grafts with amphiphilic block copolymer coatings
12/15/2005WO2005056572A3 Clustered multi-antigenic carbohydrate constructs, methods for their preparation and uses thereof
12/15/2005WO2005039501A3 Immunogenic composition and method of developing a vaccine based on fusion protein
12/15/2005WO2005021706A3 Delivery of compounds with rehydrated blood cells
12/15/2005WO2005021556A3 Modified protease inhibitors
12/15/2005WO2005018697A3 Active agent delivery systems, including a single layer of a miscible polymer blend, medical devices, and methods
12/15/2005WO2004096989A9 Single chain antigen-binding polypeptides for polymer conjugation
12/15/2005WO2004083258A3 Branched water-soluble polymers and their conjugates
12/15/2005WO2004064787A3 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
12/15/2005WO2004000211A3 Improved compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
12/15/2005WO2002094376A3 Compositions and methods for promoting or inhibiting ndpk
12/15/2005WO2002083921A8 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
12/15/2005US20050277739 Novel temperature and pH sensitive copolymers
12/15/2005US20050277609 Immunostimulatory nucleic acid molecules
12/15/2005US20050277604 Immunostimulatory nucleic acid molecules
12/15/2005US20050277584 Pharmaceutical compositions comprising cyclosporins
12/15/2005US20050277580 Antidiabetic agents; lipophilic
12/15/2005US20050277575 Therapeutic compositions and methods for treating diseases that involve angiogenesis
12/15/2005US20050277143 Formed by fusing a pinanediol bound to a solid support with a boronic or boric acid bound to a biomolecule; an array may be constructed by preparing the conjugate at a plurality of spatially distinct reaction sites on the solid support
12/15/2005US20050276893 Method for producing fat and/or solids from beans and compositions containing polyphenols
12/15/2005US20050276867 Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative
12/15/2005US20050276861 Ex-vivo application of solid microparticulate therapeutic agents
12/15/2005US20050276859 Preparation of biodegradable, biocompatible microparticles containing a biologically active agent
12/15/2005US20050276858 Bifunctional-modified hydrogels
12/15/2005US20050276855 Composition and method using local application of lipophilic lathyrogens sustained release formulations
12/15/2005US20050276854 Bioimplant formulation
12/15/2005US20050276853 Chronotherapeutic dosage forms and methods of treatment using chronotherapy
12/15/2005US20050276852 Sustained release formulations of guaifenesin and additional drug ingredients
12/15/2005US20050276843 An aerosol drug delivery device containing PTH, cyclodextrin, and didecanoylphophatidylcholine that provides droplets of 25 to 700 microns in size; improved bioavailability; osteoporosis
12/15/2005US20050276841 Biodegradable drug-polymer delivery system
12/15/2005US20050276840 Method and system for weight management
12/15/2005US20050276839 Appetite satiation and hydration beverage
12/15/2005US20050276823 Methods and compositions for preventing oxidative degradation of proteins
12/15/2005US20050276812 Antibody-drug conjugates and methods
12/15/2005US20050276798 with a histidine buffer and maltose; anti-HIV; higher concentrations, are storage stable, compatible with lyophilization, and safe to administer by intravenous injection
12/15/2005US20050276783 Polypeptides with the capacity to entrap drugs and release them in a controlled way
12/15/2005US20050276756 Compositions as adjuvants to improve immune responses to vaccines and methods of use
12/15/2005US20050274671 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid
12/15/2005DE102004022927A1 1,4 O-verknüpfte Saccharose-Derivate zur Stabilisierung von Antikörpern oder Antikörper-Derivaten 1,4 O-linked saccharose derivative instruments for stabilizing antibodies or antibody derivatives
12/15/2005DE10157260B4 Streichfähige Salbe mit Ozoniden und Peroxiden von Fettsäuren oder deren Estern Spreadable ointment with ozonides and peroxides of fatty acids or their esters
12/15/2005CA2709865A1 Method for improved breast milk feeding to reduce the risk of allergy
12/15/2005CA2608003A1 Medical uses of carrier conjugates of non-human tnf-peptides
12/15/2005CA2580305A1 Polymer based nano-carriers for the solubilization and delivery of hydrophobic drugs
12/15/2005CA2578806A1 Oral formulations of paricalcitol
12/15/2005CA2572453A1 Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface
12/15/2005CA2572348A1 Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface
12/15/2005CA2569514A1 Oral preparations and process for production thereof
12/15/2005CA2569240A1 Drug fusion comprising a polypeptide drug and an immunoglobulin heavy chain variable domain specific for serum albumin
12/15/2005CA2569067A1 Unagglomerated core/shell nanocomposite particles
12/15/2005CA2568598A1 Systems and methods for treating panic attacks
12/15/2005CA2568364A1 Methods for preparing immunogenic conjugates
12/15/2005CA2567803A1 Injectable pharmaceutical suspension comprising posaconazole
12/15/2005CA2567728A1 Griffithsin, glycosylation-resistant griffithsin, and related conjugates,compositions, nucleic acids, vectors,host cells, methods of production and methods of use
12/15/2005CA2567520A1 Maytansinoid-antibody conjugates
12/15/2005CA2567309A1 Method of stabilizing proteins
12/15/2005CA2566571A1 Treatment methods utilizing albumin-binding proteins as targets
12/15/2005CA2565500A1 Vaccine compositions comprising virosomes and a saponin adjuvant
12/15/2005CA2563697A1 Ozonized pharmaceutical composition and method
1 ... 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 ... 1712